1. Immunology/Inflammation Anti-infection
  2. Toll-like Receptor (TLR) Bacterial
  3. NAB815

NAB815 是一种 Stx2a (Kd= 0.01 μM)/TLR4 相互作用的特异性抑制剂。NAB815 抑制中性粒细胞/Stx2a 相互作用 (IC50 = 0.057 μg/mL)。NAB815 抑制白细胞和血小板产生的含 Stx2 的细胞外囊泡 (EV) 的形成,并降低其在细胞 (Vero 细胞) 和动物模型 (CD-1 小鼠) 中的毒性作用。NAB815 降低大肠杆菌感染的小鼠肾脏、尿液和膀胱中的细菌 (bacterial) 负荷。NAB815 可用于溶血性尿毒症综合征 (HUS) 的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

NAB815

NAB815 Chemical Structure

CAS No. : 1969250-99-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 Toll-like Receptor (TLR) 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

NAB815 is a specific inhibitor of the Stx2a (Kd = 0.01 μM)/TLR4 interaction. NAB815 inhibits the neutrophil/Stx2a interaction (IC50 = 0.057 μg/mL). NAB815 inhibits the formation of Stx2-containing extracellular vesicles (EVs) produced by leukocytes and platelets and reduces their toxic effects in cellular (Vero cells) and animal models (CD-1 mice). NAB815 reduces bacterial loads in the kidneys, urine, and bladders of Escherichia coli-infected mice. NAB815 is useful in the study of hemolytic uremic syndrome (HUS)[1][2].

体外研究
(In Vitro)

NAB815 (1 nM,4 小时) 可抑制 Stx2a 形成白细胞/血小板聚集体[1]
NAB815 (0.01-0.1 μg/mL,4 小时) 对人类白细胞活力有轻微影响,但对红细胞无影响,可抑制含有 Stx2a 的血小板衍生和白细胞衍生的致病性 EVs 的形成,并削弱 Stx2 诱导的 EVs 中补体因子的募集[1]
NAB815 (0.01 μg/mL) 可保护 Vero 细胞免受 Stx2a 引发的 EVs 引起的毒性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

NAB815 (0.01 μg/mL,100 μL,静脉注射,一次) 可保护 CD-1 小鼠免受游离 Stx2a 的侵害[1]
NAB815 (0.01 μg/mL,300 μL,静脉注射,一次) 可保护人类 EVs CD-1 小鼠免受 EV 相关的 Stx2a 的侵害[1]
NAB815 (0.5-2 mg/L,0.2 mL,皮下注射,每天两次,连用三天) 可降低大肠杆菌感染的雌性 OF-1 小鼠肾脏、尿液和膀胱中的细菌负担[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: CD-1 mice(6-7 weeks old 21-26 g, female) intoxicated with Stx2a (10 and 15 pg/g) [1]
Dosage: 0.01 μg/mL, 100 μL
Administration: i.v., once
Result: Improved survival rate without changing body weight, decreased intestinal damage.
Animal Model: Human EVs (10,400–20,800 g) CD-1 mice(6-7 weeks old 21-26 g, female) intoxicated with Stx2a (10 and 15 pg/g)[1]
Dosage: 0.01 μg/mL, 300 μL
Administration: i.v., once
Result: Decreased serum creatinine and a significant rise in serum urea, number of cells with acute tubular injuries (ATIs).
Animal Model: E. coli-infected (5 × 108) female OF-1 mice (27-33 g)[2]
Dosage: 0.5, 2, 2 mg/L, 0.2 mL
Administration: s.c., twice a day, 3 days
Result: Reduced CFU levels.
分子量

1175.42

Formula

C55H94N14O14

CAS 号
Sequence

Octanoic-{Dab}-Thr-{d-Thr}-{Dab}-{Dab}-{d-Phe}-Leu-{Abu}-{Dab}-Thr (lactam bridge: Dab4-Thr10)

Sequence Shortening

Octanoic-{Dab}-T-{d-Thr}-{Dab}-{Dab}-{d-Phe}-L-{Abu}-{Dab}-T (lactam bridge: Dab4-Thr10)

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
NAB815
目录号:
HY-P11232
需求量: